中国·威尼斯-www.9499.com|登录入口

Stock Code:300238Mailbox Login
close

History

History

2020

Symbiox® Listed in Catalog of Medicine covered by national medical insurance system 

2020
2019

First in class drug Symbiox ® obtained registration certificate

2019
2018

Mr. Zhang Yongming became controlling shareholder

2018
2017

Guanhao acquired Beijing Wenfeng Tianji Pharma, and Guangdong Zhonghao Pharma.

2017
2016

Guanhao acquired Zhuhai Sunny Medical Device Co., Ltd.

2016
2014

Guanhao and Peking University co-founded Bei Hao Research Stem Cell and Regenerative Research Institute

2014
2013

Guanhao began industrialization of immunocyte storage technology

2013
2013

Founded "Guangdong Guanhao Life and Health Industry Park"

2013
2011

Listed on the GEM board of China Shenzhen Stock Exchange

2011
2009

Awarded by the National Development and Reform Commission for the Construction of the State’s High-tech Industrialization Demonstration Project

2009
2008

Awarded by the National Development and Reform Commission for the construction of the National Engineering Laboratory for Regenerative Implantable Medical Devices

2008
2006

Obtained Approval for first product NormalGEN® dura repair patch 

2006